These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 1420559)
1. Comparison of the inhibitory effect of sulfamonomethoxine and other sulfonamides on capsule formation of Bordetella bronchiseptica. Kuwano A; Ito T; Tachi H; Hiramune T J Vet Med Sci; 1992 Oct; 54(5):1057-9. PubMed ID: 1420559 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of sulfamonomethoxine on capsule formation of Bordetella bronchiseptica. Kuwano A Zentralbl Veterinarmed B; 1991 Nov; 38(9):685-8. PubMed ID: 1789025 [TBL] [Abstract][Full Text] [Related]
3. Molecular basis of resistance to trimethoprim, chloramphenicol and sulphonamides in Bordetella bronchiseptica. Kadlec K; Kehrenberg C; Schwarz S J Antimicrob Chemother; 2005 Sep; 56(3):485-90. PubMed ID: 16046466 [TBL] [Abstract][Full Text] [Related]
4. [Quantitative study of the sensitivity of Bordetella bronchiseptica and Pasteurella multocida to sulfonamides]. van Klingeren B; Dessens-Kroon M; Verheuvel M Tijdschr Diergeneeskd; 1987 Feb; 112(4):213-7. PubMed ID: 3824346 [TBL] [Abstract][Full Text] [Related]
5. Acid tolerance response of Bordetella bronchiseptica in avirulent phase. Fingermann M; Hozbor D Microbiol Res; 2015 Dec; 181():52-60. PubMed ID: 26640052 [TBL] [Abstract][Full Text] [Related]
6. Bordetella bronchiseptica responses to physiological reactive nitrogen and oxygen stresses. Omsland A; Miranda KM; Friedman RL; Boitano S FEMS Microbiol Lett; 2008 Jul; 284(1):92-101. PubMed ID: 18462394 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility of Pasteurella multocida and Bordetella bronchiseptica from dogs and cats as determined in the BfT-GermVet monitoring program 2004-2006. Schwarz S; Alesík E; Grobbel M; Lübke-Becker A; Werckenthin C; Wieler LH; Wallmann J Berl Munch Tierarztl Wochenschr; 2007; 120(9-10):423-30. PubMed ID: 17939457 [TBL] [Abstract][Full Text] [Related]
8. Role played by the response regulator Ris in Bordetella bronchiseptica resistance to macrophage killing. Zimna K; Medina E; Jungnitz H; Guzmán CA FEMS Microbiol Lett; 2001 Jul; 201(2):177-80. PubMed ID: 11470358 [TBL] [Abstract][Full Text] [Related]
9. Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activities. Schaeffer LM; McCormack FX; Wu H; Weiss AA Infect Immun; 2004 Dec; 72(12):7124-30. PubMed ID: 15557636 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment of Bordetella bronchiseptica pneumonia by minocycline in anti-neutrophil cytoplasmic antibodies-associated vasculitis patient. Ito Y; Uemura K J Infect Chemother; 2016 Dec; 22(12):808-810. PubMed ID: 27424791 [TBL] [Abstract][Full Text] [Related]
12. Haemagglutinating and adhesive activity of Bordetella bronchiseptica treated with sub-minimal inhibitory concentrations of gentamicin. Semjén G; Magyar T Acta Vet Hung; 1991; 39(3-4):121-6. PubMed ID: 1785432 [TBL] [Abstract][Full Text] [Related]
14. Chromosome-borne class A BOR-1 beta-Lactamase of Bordetella bronchiseptica and Bordetella parapertussis. Lartigue MF; Poirel L; Fortineau N; Nordmann P Antimicrob Agents Chemother; 2005 Jun; 49(6):2565-7. PubMed ID: 15917575 [TBL] [Abstract][Full Text] [Related]
15. Expression of urease does not affect the ability of Bordetella bronchiseptica to colonise and persist in the murine respiratory tract. McMillan DJ; Medina E; Guzmán CA; Walker MJ FEMS Microbiol Lett; 1999 Sep; 178(1):7-11. PubMed ID: 10483716 [TBL] [Abstract][Full Text] [Related]